Abstract
BackgroundIvacaftor approval was extended to people with cystic fibrosis (CF) and an R117H variant in 2014 in the USA. This observational, real-world, postapproval study evaluated long-term outcomes among people with...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have